Abstract: Sexual dimorphisms of atherosclerosis and the susceptibility to arrhythmias and antiarrhythmic treatment have been reported. This study investigated acute effects of amiodarone on endothelium-dependent relaxation in the aorta of male and female apoE 0 mice with advanced atherosclerosis. Amiodarone tissue uptake was quantified by high-performance liquid chromatography, and xanthine oxidase-dependent superoxide anion formation was investigated in vitro in presence or absence of amiodarone. Incubation with amiodarone for 30 min improved endothelium-dependent relaxation, which was associated with rapid vascular accumulation of amiodarone (P , 0.001) that was sex-dependent. In males, reduced endothelium-dependent relaxation was improved by amiodarone (from 88 6 3% to 100 6 2%, P , 0.01). Spontaneous phasic contractions, which were greater in females than in males (P , 0.001), were completely abolished by amiodarone (P , 0.0001). Amiodarone also inhibited generation of superoxide anion (P , 0.0001). These data show that amiodarone rapidly accumulates in atherosclerotic vascular tissue, abolishes vascular autorhythmicity, and improves endothelium-dependent function in atherosclerotic arteries. Antioxidant and vasodilator effects following amiodarone administration may contribute to its antiarrhythmic effects.
T he incidence of coronary artery disease is lower in premenopausal women than in age-matched men, 1 suggesting protective cardiovascular effects of endogenous estrogens. Thus, male sex and/or estrogen deficiency are considered important cardiovascular risk factors contributing to the development of atherosclerosis. In addition, a large body of experimental data demonstrated atheroprotective effects of estrogen, 2 including inhibition of lipid peroxidation. 3 Moreover, sex differences have been described for cardiac repolarization, suggesting effects of endogenous estrogens on arrhythmogenesis. 4 Interestingly, JT interval prolongation following sotalol treatment as well as a higher incidence of drug-induced torsades de pointes ventricular tachycardia in women compared with men have been noticed, 4 also suggesting sex differences in the responsiveness to antiarrhythmic drug treatment.
Amiodarone, for which antiarrhythmic activity was first reported almost 40 years ago, 5, 6 is considered the gold standard for acute pharmacological treatment of life-threatening ventricular tachyarrhythmias in high-risk patients. 7 The mechanisms by which acute or chronic amiodarone treatment inhibits arrhythmogenesis include blockade of ion channels, prolongation of action potential duration, as well as inhibitory effects on the sympathetic nervous system. 8 Interestingly, amiodarone was initially developed during a systematic search for a potent coronary dilator for the therapy of angina pectoris. 9 Amiodarone inhibits lipoprotein oxidation 10 and may protect myocytes against oxidative stress-mediated injury by scavenging oxygen-derived free radicals under certain conditions. 11 Thus, it is possible that, due to its antioxidant properties, amiodarone could increase bioactivity of nitric oxide (NO) 12 and exhibit beneficial antiarrhythmic effects in patients with cardiovascular disease extending beyond its electrophysiological properties. This notion would be supported further by recent studies suggesting that certain antioxidants may have antiarrhythmic activity and that reactive oxygen species (ROS) contributes to arrhythmogenesis. [13] [14] [15] Atherosclerosis is a systemic inflammatory disease characterized by vascular injury, formation of superoxide anion, and reduced bioactivity of NO, resulting in impaired endothelium-dependent vasodilatation. 16 Whether and by which mechanisms amiodarone acutely affects endotheliumdependent relaxation in atherosclerosis, or whether amiodarone affects superoxide anion bioactivity, is currently unknown. Importantly, it is also not known whether vascular effects of amiodarone are sex-dependent, as has been suggested by studies with other antiarrhythmic drugs. 4 Therefore, we investigated acute effects of amiodarone on vascular reactivity in aged male and female mice with advanced human-like atherosclerosis. We also determined acute effects of amiodarone on superoxide anion production, using a xanthine/xanthine oxidase-based in vitro system.
METHODS

Animals
Male and female apolipoprotein E-deficient mice (apoE 0 , n = 9-10/group; Jackson Laboratory, Bar Harbor, ME) were sacrificed at 10 months of age. At sacrifice, body weight was 32 6 0.7 g in males and 25 6 0.5 g in females (P , 0.0001). Animals were housed at the institutional animal facilities and received standard rodent chow and tap water ad libitum. Experiments were in accordance with the institutional guidelines and the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health.
Vascular Function Experiments
Animals were anesthetized with ketamine (100 mg/kg body weight), xylazine (20 mg/kg), and acepromazine (3 mg/kg) intraperitoneally and sacrificed by exsanguination. Thoracic aorta was isolated immediately, excised and placed into cold Krebs-Ringer bicarbonate solution (4°C; NaCl 118.6 mmol/L, KCl 4.7 mmol/L, CaCl 2 2.5 mmol/L, KH 2 HPO 4 1.2 mmol/L, MgSO 4 1.2 mmol/L, NaHCO 3 25.1 mmol/L, ethylenediamine tetraacetic acid calcium disodium 0.026 mmol/L, glucose 11.1 mmol/L), cleaned from perivascular tissue under a microscope (Olympus SZX9, Japan), and cut in vascular rings (length 3 mm). Aortic rings were mounted onto tungsten wire (100 mm), placed in organ chambers containing Krebs-Ringer solution (37°C, pH 7.4, 95% O 2 , 5% CO 2 ), and connected to force transducers (Hugo Sachs, Germany) for isometric tension recording. Rings were repeatedly exposed to KCl 100 mmol/L (iso-osmotically replaced) until optimal tension for generating force during isometric contraction was reached (1.75 g). Rings were preincubated with either amiodarone hydrochloride (34 mg/mL) or solvent control [dimetylsulfoxide (DMSO), 4 mL/mL] for 30 min. This concentration of amiodarone was chosen based on our previous studies in patients 17 to achieve tissue levels comparable to those found in cardiovascular tissue of patients chronically treated with amiodarone. 18, 19 The time point of 30 min for preincubation was based on studies in the clinical setting of acute antiarrhythmic treatment in which the first dose of amiodarone is commonly infused for 20 min up to 2 hours. 7 In rings precontracted with phenylephrine (70% to 80% of KCl), endothelium-dependent reactivity was investigated using acetylcholine (0.1 nmol/L to 30 mmol/L). Endotheliumindependent relaxation was determined using sodium nitroprusside (10 mmol/L). 16 After experiments, rings were blotted dry, snap-frozen in liquid nitrogen, and kept at -80°C until further analysis.
Histological Analysis
Aortic tissue samples were transferred in 10% phosphate-buffered saline formalin and embedded in paraffin. Paraffin sections (5 mm) of aorta were deparaffinized, rehydrated in graded alcohols, and stained with hematoxylin and eosin.
Tissue Analysis
Amiodarone tissue concentrations in vascular rings were measured by means of high-performance liquid chromatography (HPLC) as described. 19 Briefly, samples were cut, dried, and weighed. An appropriate volume of HPLC grade methanol was added and tissues were suspended in an appropriate volume of di-N-desethylamiodarone hydrochloride (DDEA) as internal standard and homogenized as described previously. 19 Calibration samples were prepared by adding appropriate amiodarone amounts, DDEA to blank tissues, and homogenized. After centrifugation (5000g for 5 min at 20°C), 50 mL of supernatant was injected into the chromatograph. Analysis was performed using a solvent delivery pump (GBC Scientific Equipment, Australia), an autosampler (Bromma, Sweden), and a variable-wavelength detector set at 242 nm (GBC, Australia). Assays were operated under the following conditions: Nucleosil 120-5 C18, 12.5 3 4.0 mm reverse-phase column (Macherey-Nagel, Switzerland) maintained at 40°C; mobile phase methanol:water: 25% NH 3 (340:45:3.0 w/w); flow 1.5 mL/min; pressure 10 mPa. Signals were processed by WinChrom software (GBC, Australia). Tissue concentrations were calculated as described and expressed as micrograms per milligram of tissue. 20 
Antioxidant Activity Assay
The effect of amiodarone on superoxide anion generated in vitro using an enzyme-based, cell-free system constituting of xanthine and xanthine oxidase in aerated Krebs-Ringer solution was studied. The superoxide anion was quantified, as described, using 8-amino-5-chloro-7-phenylpyridol[3,4-d]pyridazine-1,4(2H,3H)dione sodium salt (L-012), a highly sensitive chemiluminescence probe, which unlike lucigenin lacks redox cycling, 21 with a luminometer (Lumat LB 9507 Berthold; Bad Wildbad, Germany). Briefly, in 5-mL round bottom polystyrene tube (12 3 75 mm; BD Biosciences, Franklin Lakes, NJ), the required concentrations of xanthine (20 mM; 90 mL) and L-012 (100 mM; 30 mL) were injected into Krebs-Ringer solution (37°C, pH 7.4). Between the injections, there was a delay of 1 sec. As defined by the experimental setup, the required concentrations of xanthine oxidase (5 mU), amiodarone (34 mg/mL dissolved in DMSO), or superoxide dismutase (200 U/mL) were added to the KrebsRinger solution before starting the injections. Superoxide dismutase was used to confirm the specificity of the assay. In the absence of amiodarone, DMSO (0.5%) was added to the reaction tube as vehicle control. The final reaction volume including drugs and/or enzymes was set to 600 mL. After adding the reaction substances the program was started. Twenty measurements were performed over a period of 5 min and each measurement was for 10 sec with a delay measurement time of 5 sec. The emitted chemiluminescence corresponding to the superoxide formation was calculated after subtracting the background. Superoxide anion formation was determined at 1 min, at 5 min, and total superoxide anion formation was determined by cumulative measurements of chemiluminescence signals from minute 1 to minute 5.
Drugs
DDEA was synthesized by condensing the amiodarone analogue 2-n-butyl-3-(3,5-diiodo-4-hydroxybenzoyl)benzofuran 20 with 2-chloroethylamine hydrochloride in presence of K 2 CO 3 in toluene:water (1:1). 17, 20 The residue was purified
by low-pressure chromatography as described. 17 Pure DDEA was isolated as a hydrochloride salt and purified by re-crystallization in acetone (0.3 g; yield 24%). Solvents for HPLC were of HPLC grade (Merck, Germany). Amiodarone hydrochloride was obtained from Sanofi, France. Acetylcholine chloride, phenylephrine hydrochloride, sodium nitroprusside dihydrate, and xanthine oxidase were from Sigma-Aldrich, Switzerland. L-012 was from Wako Pure Chemical Industries, Japan. Acepromazine was purchased from Fatro, Italy, ketamine from Chassot, Switzerland, and xylazine from Bayer, Switzerland. Stock solutions were diluted in Krebs solution to the required final concentration before use. Amiodarone hydrochloride and DDEA were dissolved in DMSO.
Calculations and Statistical Analysis
Data are expressed as means 6 SEM, and n equals the number of animals. Relaxation was expressed as percent of precontraction and the degree of spontaneous vascular rhythmic oscillation was expressed as percent of contraction to KCl 100 mmol/L. EC 50 values (as negative logarithm: pD 2 ), area under the curve (AUC), and maximal responses (E max ) were calculated by non-linear regression analysis. 22 For comparisons between two values, the unpaired Student's t-test was used. A P value ,0.05 was considered significant.
RESULTS
Effect of Sex on Vascular Reactivity
Endothelium-dependent relaxation was reduced in male but not in female apoE 0 mice (88 6 3% vs. 99 6 4%, P , 0.05; Fig. 1 ). Endothelium-independent relaxation to sodium nitroprusside was similar in males and females (112 6 3% vs. 113 6 2%, P = NS). Advanced atherosclerotic lesions were present in both male and female apoE 0 mice (Fig. 2) .
Effect of Sex on Vascular Amiodarone Uptake
Amiodarone rapidly accumulated in atherosclerotic arteries of apoE 0 mice within 120 minutes (Fig. 3 ). Amiodarone tissue uptake was more than double in arteries derived from females than from males (4.5 6 0.5 vs. 2.2 6 0.2 mg/mg, P , 0.001, Fig. 3 ).
Rapid Effects of Amiodarone on Vascular Reactivity
Acute treatment with amiodarone for 30 min normalized impaired endothelium-dependent relaxation in the aorta of males (from 88 6 3% to 100 6 2%, P , 0.01, Fig. 1B) . Endothelium-independent relaxation to sodium nitroprusside was unaffected by amiodarone (females: 113 6 3% vs. 113 6 2%, P = NS; males: 112 6 3% vs. 112 6 3%, P = NS). Precontracted atherosclerotic arteries displayed pronounced spontaneous and phasic rhythmic contractions in response to acetylcholine (original recording, Fig. 4A , upper tracing) with the amplitude being 2-fold higher in females as compared with males (23 6 2 vs. 11 6 2% KCl, P , 0.001, Fig. 4B , left bars). Amiodarone pretreatment for 30 min completely prevented vascular autorhythmicity in both females and males (P , 0.0001, Fig. 4B ).
Antioxidant Effects of Amiodarone
Superoxide anion was generated using an in vitro enzyme-based system of xanthine/xanthine oxidase and the specificity of the assay was confirmed by completely abrogating the chemiluminescence signal by adding CuZn-superoxide dismutase (200 U/mL, data not shown). 23 Incubation with amiodarone (34 mg/mL) attenuated the chemiluminescence signal (P , 0.0001 vs. solvent control, Fig. 5A ). Interestingly, this inhibitory effect was time-dependent and most potent at the 5 min time point (-78%, P = 0.0001, Fig. 5C ). FIGURE 1. Acute effects of amiodarone on endothelium-dependent relaxation in experimental atherosclerosis. Aortic rings obtained from female (A, s) and male apoE 0 mice (B, n) with atherosclerosis pretreated for 30 min with either amiodarone (34 mg/ mL, AMI, , :) or solvent control DMSO (CTL, s, n) were precontracted and exposed to cumulative doses of acetylcholine. Endothelium-dependent relaxation in the aorta was reduced in males, but not in females. †P , 0.05, panels A + B. Amiodarone acutely improved maximal endothelium-dependent relaxations in the aorta of male mice (*P , 0.05 for E max and AUC, panel B) and slightly increased sensitivity to acetylcholine in females (P , 0.05 for pD 2 , panel A). Data are means 6 SEM, n = 8-10/group. *P , 0.05 vs. solvent control, †P , 0.05 vs. female.
DISCUSSION
This study demonstrates sex differences with regard to endothelium-dependent relaxation and vascular autorhythmicity in apoE 0 mice with advanced atherosclerosis. Amiodarone, an antiarrhythmic drug, acutely improved endotheliumdependent relaxation and completely prevented acetylcholine-induced spontaneous rhythmic activity. We also show sex-dependent accumulation of amiodarone in arterial tissue after acute administration and inhibition of superoxide anion generation in vitro.
In the present study, amiodarone acutely improved endothelium-dependent relaxation in male apoE 0 mice with spontaneous atherosclerosis, whereas it had no effect in female mice in which endothelium-dependent relaxation was essentially normal. These effects of amiodarone possibly involve changes in NO bioactivity, as endothelium-dependent relaxation to acetylcholine in the aorta of these mice is almost exclusively mediated by NO. 16 This notion is further strengthened by the observation that amiodarone had no effect on endothelium-independent relaxation to sodium nitroprusside, suggesting that the drug does not affect vascular smooth muscle sensitivity to NO. Thus, the acute vascular effects of amiodarone presented here may be of clinical relevance if effective in patients with atherosclerotic coronary disease. Previous studies have demonstrated effects of amiodarone on cardiovascular hemodynamics and blood pressure after acute [24] [25] [26] including hypotension. 27 In experimental studies in dogs and guinea pig hearts, vasodilatory effects of amiodarone were only partly endotheliumdependent. 28, 29 Moreover, the amiodarone derivate KB130015 induces endothelium-independent relaxation in porcine pulmonary arteries. 30 To the best of our knowledge, this is the first study showing that amiodarone rapidly accumulates in atherosclerotic vascular tissue. Due to the known side effects of chronic amiodarone therapy, investigators have studied distribution and accumulation of amiodarone in different organ tissues. 18, 31, 32 However, there is no information as to whether amiodarone accumulates in vascular tissue in vivo, whether vascular disease affects tissue uptake, and if the kinetics of tissue uptake require chronic amiodarone treatment. Interestingly, clinical data suggest that the pharmacodynamic effect of amiodarone more closely correlates with the cumulative ingested dose than with plasma concentrations. 19 In the present study, in vitro experiments were performed using a concentration of 34 mg/mL of amiodarone. As demonstrated by our present data, using this concentration in the organ chamber resulted in sex-dependent vascular tissue concentrations of 2.2 and 4.5 mg/mg in males and females, respectively. This suggests a role for endogenous sex hormones modulating vascular tissue uptake of amiodarone. Interestingly, in clinical studies, the values measured in the vasculature were higher than concentrations in myocardial tissue of patients receiving amiodarone: 12-49 mg/g, 33 5-25 mg/g, 18 and 13-40 mg/g. 19 In preliminary experiments we found that myocardial tissue uptake concentrations achieved after in vitro incubation of 34 mg/mL under the same experimental conditions are close to those described in the literature (25.9 6 7.6 mg/g; unpublished observation, 2007); therefore, this concentration was chosen for the vascular in vitro incubation experiments. Moreover, the use of a single high concentration of amiodarone allows us to quickly achieve the target tissue concentration. Because the drug effect is related to the tissue concentration and because only nonprotein-bound amiodarone exerts pharmacologic effects and can be distributed into peripheral sites, 34 the role of plasma protein binding would be minor, whereas a quick absorption (distribution phase) is important. Additionally, preliminary results from our laboratory indicate that rapid vascular uptake of amiodarone also occurs in vascular tissue of humans (unpublished observation, 2007) .
Spontaneous phasic contractions can be detected in mice with atherosclerosis and in isolated human coronary arteries, 35, 36 particularly in arteries that display severe coronary atherosclerosis (Barton M, unpublished observation), and phasic contractions may also contribute to coronary vasospasm of epicardial coronary arteries known as ''variant'' angina or ''Prinzmetal's angina.'' 37 An unexpected finding of our study was that acute treatment with amiodarone completely abolished spontaneous vascular oscillations in atherosclerotic arteries following the administration of acetylcholine. Activation of alpha-adrenergic receptors, decreased activity of NO, 38 increased endothelin-mediated vasoconstriction, 39 and ROS 40 have all been implicated in the pathogenesis of variant angina, which can be effectively treated with Ca 2+ -channel blockers. This notion is supported by experimental studies in which rhythmic contractions of human coronary arteries have been shown to involve Ca 2+ and endothelin receptor signaling 35, 36 ; thus, it is possible that the effect of amiodarone on phasic contractions in atherosclerotic arteries was, at least in part, due to interference with any of these mechanisms. 41, 42 Interestingly and unexpectedly, the amplitude of phasic contractions was greater in females than in males, suggesting that endogenous sex hormones determine the magnitude of vascular oscillations. Functional abnormalities of microvessels also occur in patients with variant angina and may contribute to myocardial ischemia. 37 It is noteworthy that the prevalence of ischemia due to epicardial vasospasms is higher in women than in men. 37 Indeed, in premenopausal women, the frequency of variant angina is associated with low plasma levels of estradiol during the menstrual cycle, 43 and supplementation of 17b-estradiol suppresses the onset of variant angina in postmenopausal women. 44 The durations of the QT interval and the JT interval, respectively, are greater in women than in men, and women are more susceptible to proarrhythmic effects of antiarrhythmic drugs than men. 4 A recent study in patients with atrial fibrillation reported marked sex differences with regard to disease susceptibility. 45 Based on their findings, these authors proposed therapeutic consequences for female patients requiring antiarrhythmic therapy. 45 Our findings showing that amiodarone improved endothelium-dependent relaxation in atherosclerotic arteries FIGURE 5 . Effect of amiodarone on xanthine oxidase-mediated superoxide production in vitro. The effect of amiodarone (34 mg/mL, filled bars) or solvent control (CTL, open bars) on enzyme-based superoxide anion formation using xanthine/xanthine oxidase was determined in vitro and quantified by L-012-enhanced chemiluminescence. Total superoxide anion production continuously detected over 5 min was reduced by amiodarone (P , 0.0001 vs. solvent control, left panel). The antioxidant effect was more potent after 5 min (278%, P = 0.0001, right panel) than after 1 min (middle panel). Data are means 6 SEM, given in arbitrary units (AU), and are based on 3 independent experiments. *P , 0.01 vs. solvent control.
of males as well as the effect on vascular rhythmic activity may involve scavenging of ROS by amiodarone, 10, 11, 46 which would increase NO bioactivity. It is important to note that ROS has been implicated in arrhythmogenesis and thus part of the antiarrhythmic effects of amiodarone could be due to its antioxidant property. 14, 15, 47 We therefore postulated that amiodarone might have direct antioxidant effects. Using an in vitro system, this hypothesis was confirmed showing that amiodarone indeed is a rapid and potent scavenger of superoxide anion. Other mechanisms by which amiodarone could improve endothelium-dependent relaxation include changes in intracellular calcium 48 or activation of endothelial NO synthase, mechanisms which play a role in the beneficial effects of sex hormones. 49 
CONCLUSION
The findings of the present study suggest that amiodarone acutely improves endothelium-dependent vasodilation and phasic contractions in atherosclerotic arteries in a sex-dependent fashion, indicating new and rapid vasoactive properties of a well-known antiarrhythmic drug. Vasodilator effects of amiodarone could reduce the life-threatening risk for arrhythmias with variant angina or myocardial infarction by improving organ perfusion independent of sex. It remains to be determined whether amiodarone exerts similar effects also in patients receiving this drug and whether the presence of atherosclerotic vascular disease and/or risk factors affect the acute vascular activities of amiodarone to the same degree in men and women.
